Free Trial

Tempus AI (NASDAQ:TEM) Shares Up 3.4% - Should You Buy?

Tempus AI logo with Medical background

Key Points

  • Tempus AI's stock increased by 3.4% during trading, closing at $71.98, after reaching a high of $74.40.
  • Several analysts have rated Tempus AI's stock with a consensus target price of $65.36, indicating a Moderate Buy sentiment.
  • Tempus AI reported quarterly earnings showing significant revenue growth of 89.5% year-over-year, despite a net margin of -20.98% and an EPS of ($0.22).
  • Looking to export and analyze Tempus AI data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s stock price was up 3.4% during trading on Thursday . The stock traded as high as $74.40 and last traded at $71.98. Approximately 8,764,007 shares traded hands during mid-day trading, a decline of 30% from the average daily volume of 12,497,641 shares. The stock had previously closed at $69.63.

Wall Street Analyst Weigh In

Several equities analysts recently commented on TEM shares. Needham & Company LLC reissued a "buy" rating and issued a $70.00 price objective on shares of Tempus AI in a research note on Friday, August 8th. Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Morgan Stanley increased their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research note on Tuesday. BTIG Research initiated coverage on shares of Tempus AI in a research note on Friday, August 8th. They issued a "buy" rating and a $60.00 price objective for the company. Finally, Guggenheim raised their price target on shares of Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $65.36.

View Our Latest Analysis on TEM

Tempus AI Stock Performance

The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.56. The company's 50-day moving average price is $62.64 and its two-hundred day moving average price is $58.28. The company has a market capitalization of $12.23 billion, a price-to-earnings ratio of -59.33 and a beta of 4.98.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company had revenue of $314.64 million during the quarter, compared to analysts' expectations of $296.84 million. During the same period in the prior year, the company posted ($6.86) earnings per share. Tempus AI's revenue for the quarter was up 89.5% compared to the same quarter last year. On average, equities research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Activity at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 166,250 shares of the stock in a transaction on Monday, July 28th. The shares were sold at an average price of $62.87, for a total transaction of $10,452,137.50. Following the completion of the sale, the chief executive officer directly owned 9,274,033 shares in the company, valued at $583,058,454.71. This represents a 1.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Ryan Fukushima sold 5,000 shares of the firm's stock in a transaction on Monday, July 7th. The stock was sold at an average price of $60.00, for a total transaction of $300,000.00. Following the completion of the sale, the chief operating officer owned 145,000 shares of the company's stock, valued at $8,700,000. The trade was a 3.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 758,772 shares of company stock valued at $51,005,175 over the last 90 days. 27.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Tempus AI

Large investors have recently bought and sold shares of the stock. Operose Advisors LLC acquired a new stake in Tempus AI in the fourth quarter worth $25,000. Concord Wealth Partners grew its holdings in shares of Tempus AI by 308.0% during the second quarter. Concord Wealth Partners now owns 408 shares of the company's stock valued at $26,000 after buying an additional 308 shares during the last quarter. Allworth Financial LP grew its holdings in shares of Tempus AI by 5,000.0% during the second quarter. Allworth Financial LP now owns 459 shares of the company's stock valued at $29,000 after buying an additional 450 shares during the last quarter. Cherry Tree Wealth Management LLC acquired a new position in shares of Tempus AI during the first quarter valued at about $31,000. Finally, SouthState Corp grew its holdings in shares of Tempus AI by 3,761.5% during the second quarter. SouthState Corp now owns 502 shares of the company's stock valued at $32,000 after buying an additional 489 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Tempus AI Right Now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines